BP000279-CHM-250: Recombinant Human Macrophage-Derived Chemokine (CCL22)
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 69 amino acids and having a molecular mass of 8.1 kDa.
Determined by its ability to chemoattract human T cells using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 1,000-10,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000279-CHM-279: Recombinant Rat Macrophage-Derived Chemokine (CCL22)
Source: E. coli-derived.
Fully biologically active when compared to standard. Determined by its ability to chemoattract human activated lymphocytes using a concentration range of 10.0-100.0 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000279-CHM-367: Recombinant Human Macrophage-Derived Chemokine (CCL22), His Tag
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 90 amino acids (25-93 a.a.) and having a molecular mass of 10.3 kDa.
Purity > 95%, by SDS-PAGE.BP000279-CHM-370: Recombinant Mouse Macrophage-Derived Chemokine (CCL22)
Source: E. coli-derived.
A non-glycosylated, Polypeptide chain containing 68 amino acids and having a molecular mass of 7.8 kDa.
Determined by its ability to chemoattract human activated lymphocytes using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.